These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20835733)

  • 21. Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis.
    Angelico M; Di Paolo D; Trinito MO; Petrolati A; Araco A; Zazza S; Lionetti R; Casciani CU; Tisone G
    Hepatology; 2002 Jan; 35(1):176-81. PubMed ID: 11786974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
    Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience.
    Chang MS; Olsen SK; Pichardo EM; Stiles JB; Rosenthal-Cogan L; Brubaker WD; Guarrera JV; Emond JC; Brown RS
    Transplantation; 2013 Apr; 95(7):960-5. PubMed ID: 23545507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entecavir and other nucleos(t)ide analogs prophylaxis in hepatitis B virus-related liver transplantation: long-term efficacy and safety.
    Darweesh SK; Gad AA; Akroof K; ElLatif ZA
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):607-612. PubMed ID: 30724767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation.
    Di Paolo D; Tisone G; Piccolo P; Lenci I; Zazza S; Angelico M
    Transplantation; 2004 Apr; 77(8):1203-8. PubMed ID: 15114086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.
    Roque-Afonso AM; Feray C; Samuel D; Simoneau D; Roche B; Emile JF; Gigou M; Shouval D; Dussaix E
    Gut; 2002 Jan; 50(1):95-9. PubMed ID: 11772974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B infection awareness, vaccine perceptions and uptake, and serological profile of a group of health care workers in Yaoundé, Cameroon.
    Tatsilong HO; Noubiap JJ; Nansseu JR; Aminde LN; Bigna JJ; Ndze VN; Moyou RS
    BMC Public Health; 2016 Aug; 15():706. PubMed ID: 27487845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for de novo hepatitis B infection in pediatric living donor liver transplantation.
    Rao W; Xie M; Yang T; Zhang JJ; Gao W; Deng YL; Zheng H; Pan C; Liu YH; Shen ZY
    World J Gastroenterol; 2014 Sep; 20(36):13159-66. PubMed ID: 25278711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.
    Skagen CL; Jou JH; Said A
    Clin Transplant; 2011; 25(3):E243-9. PubMed ID: 21323735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transplantation from hepatitis B virus core antibody-positive donors: prophylaxis with hepatitis B immunoglobulin.
    Veroux M; Corona D; Ekser B; Giaquinta A; Tallarita T; De Martino C; Gentile F; Virgilio C; Gagliano M; Fiamingo P; Veroux P
    Transplant Proc; 2011 May; 43(4):967-70. PubMed ID: 21620027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.
    Loss GE; Mason AL; Blazek J; Dick D; Lipscomb J; Guo L; Perrillo RP; Eason JD
    Clin Transplant; 2001; 15 Suppl 6():55-8. PubMed ID: 11903388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic Strategy Against De Novo Hepatitis B Virus Infection for Pediatric Recipients Who Receive Hepatitis B Core Antibody-Positive Liver Grafts.
    Song Z; Dong C; Meng X; Sun C; Wang K; Qin H; Han C; Yang Y; Zhang F; Zheng W; Chen J; Duan K; Bi B; Gao W
    Liver Transpl; 2021 Jan; 27(1):96-105. PubMed ID: 32511854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
    Rosenau J; Kreutz T; Kujawa M; Bahr MJ; Rifai K; Hooman N; Finger A; Michel G; Nashan B; Kuse ER; Klempnauer J; Tillmann HL; Manns MP
    J Hepatol; 2007 Apr; 46(4):635-44. PubMed ID: 17316869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term protection against hepatitis B in pediatric liver recipients can be achieved effectively with vaccination after transplantation.
    Kwon CH; Suh KS; Yi NJ; Chang SH; Cho YB; Cho JY; Lee HJ; Seo JK; Lee KU
    Pediatr Transplant; 2006 Jun; 10(4):479-86. PubMed ID: 16712607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.
    Usui M; Sugimoto K; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Takei Y; Isaji S
    Transplant Proc; 2016 May; 48(4):1179-83. PubMed ID: 27320582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?
    Takaki A; Yagi T; Yasunaka T; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Sato D; Nobuoka D; Utsumi M; Yasuda Y; Nakayama E; Miyake Y; Ikeda F; Shiraha H; Nouso K; Fujiwara T; Yamamoto K
    J Gastroenterol; 2013 Dec; 48(12):1373-83. PubMed ID: 23435670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants.
    Uemoto S; Sugiyama K; Marusawa H; Inomata Y; Asonuma K; Egawa H; Kiuchi T; Miyake Y; Tanaka K; Chiba T
    Transplantation; 1998 Feb; 65(4):494-9. PubMed ID: 9500622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.